National Health Surveillance Agency of Brazil-Anvisa had earlier denied permission to import Covaxin after authorities found that the Indian plant in which the jab was being made did not meet the Good Manufacturing Practice (GMP) requirements.from Industry-Economic Times
Read The Rest:economictimes...
